This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window
Journal of Economic Perspectives: Vol. 7 No. 3 (Summer 1993)
JEP Volume. 7, Issue 3 | 
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter
Full-text Article (Complimentary)
View Comments on This Article (0) | Login to post a comment
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter
Explore:
Pricing, Profits, and Technological Progress in the Pharmaceutical Industry
Article Citation
Scherer, F M. 1993. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry."
Journal of Economic Perspectives,
7(3): 97-115.
DOI: 10.1257/jep.7.3.97
DOI: 10.1257/jep.7.3.97
Abstract
The decades-old debate over pharmaceutical industry prices, profits, and innovation has again intensified. A number of events coalesced to refocus public interest on pharmaceuticals. Contributing to public concern were Bureau of Labor Statistics price index increases for pharmaceuticals far outpacing those for the products of other industries. Another prominent characteristic of the pharmaceutical industry has been its extraordinarily high reported profitability. This article examines the phenomena that precipitated the current pharmaceuticals debate, their historical antecedents, and the principal questions at issue. In the author's considered judgment, a pell-mell march toward regulation of pharmaceutical industry pricing could seriously impair the industry's incentives for investment in new products.
Article Full-Text Access
Full-text Article (Complimentary)
Authors
Scherer, F. M. (Harvard U)
JEL Classifications
L65: Chemicals; Rubber; Drugs; Biotechnology
Comments
View Comments on This Article (0) | Login to post a comment
